Daily Archives

2 Articles

Financial Company/Financial Expert

Equities First Holdings UK

Posted by JacobT on

Equities First Holdings UK is the only global company that provide low-rate lending. The offices located in the U.S., Australia, Hong Kong, Bangkok, and Perth are always there to help individuals expand and grow. It’s easy to apply and qualify for a stock-based loan. There are also other options like a margin loan, which you need to qualify for.

It’s important in business, to have the capital you need to be successful. At Equities First Holdings UK, you can find the financial solutions you need, and reach the financial goals that you are trying to achieve. It’s a company to help solve money issues or for companies to find the cash to expand, and learn more about Equities First Holdings.

Doctors

Mikhail Blagosklonny Case for the Use of Rapamycin in Cancer Treatment

Posted by JacobT on

In the 21st century, cancer has been one of the major killer diseases in the world. Most cancers are brought about by genetic mutation due to environmental exposure. Just a small percentage of it is due to genetic inheritance. Some of the ecological factors are chemicals in alcohol and tobacco smoke, radiations, poor eating habits, and lack of exercise, and body infections.

Cancer treatment can be in four ways depending on the type of cancer, the stage of cancer diagnosis and the general well-being of the person. They include radiation therapy, chemotherapy, surgery and targeted therapy.

Mikhail Blagosklonny is one of the dedicated oncologists in America. His passion for medical research in oncology specifically in the use of Rapamycin is overwhelming. He is renowned for promoting the use of this cancer drug to increase the lifespan of the patients.

Rapamycin is used in patients who have gone through organ transplant because of its immunosuppressant properties. In the case of organ transplant, the body can reject the new organ. Hence, doctors prescribe an anti-rejection drug. These drugs have adverse effects on the new organ when used over an extended period. Rapamycin, being an immunosuppressive drug, is known to have low levels of toxicity towards the organ.

It is also known to treat patients with the hemolytic uremic syndrome. This is a disease characterized by anemia, low number of platelets, and kidney failure. This can only be treated through a kidney transplant. After transplant to prevent the new kidney from infection, the patient has to take calcium inhibitors.

Rapamycin is used to treat many other diseases. Research is still in progress for the use of Rapamycin to increase the lifespan of human beings, in the treatment of Alzheimer’s disease, in the treatment of systemic lupus erythematous, and the treatment of Muscular dystrophy.

The main reason why Mikhail Blagosklonny is dedicated to research in oncology is to devise a cure for cancer that is less painful and affordable to all. Today, cancer treatment is too expensive, especially in the developing countries. The current treatment methods inflict a lot of pain on the patients. The number of people who die of cancer in developed countries is less, compared to the developing countries, but we have not yet found an efficient and accurate cure for cancer.

Mikhail’s medical research will soon pay off when he invents a cure for cancer that is accurate and effective. According to him, an effective and precise cure for cancer is one that does not kill the normal and healthy cells of the body. This is because these cells are important in the recovery process of the individual. He wants to inspire more people through his research and findings to continue from where he will leave.

About Mikhail Blagosklonny

He is a researcher and a professor of oncology at the Roswell Park Cancer Institute in New York. He is also the chief editor of Oncotarget, which publishes research in oncology and increasing the lifespan of human beings.